Business

Abbott settles patent suit with Sandoz over antibiotic Omnicef

Posted June 30, 2010 11:00 pm

Abbott Laboratories said it settled a patent-infringement lawsuit filed against Novartis AG's Sandoz unit over generic versions of the antibiotic Omnicef.

Terms are confidential, said Scott Stoffel, a spokesman for Abbott. The companies agreed to end the case, according to a June 29 filing in federal court in Chicago. Abbott and Sandoz a week ago settled a suit over the antibiotic Biaxin XL.

Abbott lost an appeals court case last year seeking to stop sales of Sandoz's generic version of Omnicef until a trial is held. Companies including Teva Pharmaceutical Industries Ltd. also sell copies of the drug. U.S. sales of Omnicef plunged to $3 million in 2009 from $235 million in 2007 because of competition from generic copies, according to Libertyville Township-based Abbott's annual report.

The case is Abbott Laboratories v. Sandoz Inc., 07cv1721, U.S. District Court for the Northern District of Illinois (Chicago).

Article Comments

Article Categories
Business Counties Lake County

Article Comments

Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.